News

BMJ1d
Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change
1 Department of Internal Medicine, Division of Rheumatology, University Hospital of Maastricht and CAPHRI Research Institute University of Maastricht, Maastricht, The Netherlands 2 Department of ...
BMJ2d
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis
Background Studies examining the relationship between serological status (rheumatoid factor and/or anticitrullinated antibody) and rituximab treatment outcome in rheumatoid arthritis (RA) have been ...
BMJ3d
Predictive factors of work disability in rheumatoid arthritis: a systematic literature review
1 Coronel Institute for Occupational and Environmental Health, Academic Medical Centre, Research Institute Amsterdam Centre for Health and Health Care Research (AmCOGG), Amsterdam, The Netherlands 2 ...
BMJ3d
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
Objectives To compare over 2 years the safety, efficacy and radiographic outcomes of subcutaneous abatacept versus adalimumab, in combination with methotrexate (MTX), in patients with rheumatoid ...
BMJ3d
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
Objectives: To identify the main causes of morbidity and mortality in patients with antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and immunological parameters with ...
BMJ3d
Erosive hand osteoarthritis: its prevalence and clinical impact in the general population and symptomatic hand osteoarthritis
1 Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands 2 Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands 3 Department of ...
BMJ6d
EULAR recommendations for patient education for people with inflammatory arthritis
19 Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands Correspondence to Dr Heidi A Zangi, National Advisory Unit on Rehabilitation in ...
BMJ7d
Quality indicators for the primary care of osteoarthritis: a systematic review
Design Systematic review and narrative synthesis. Data sources Electronic reference databases (MEDLINE, EMBASE, CINAHL, HMIC, PsychINFO), quality indicator repositories, subject experts. Eligibility ...
BMJ10d
Psoriasis: epidemiology, clinical features, and quality of life
Psoriasis is a common chronic, recurrent, immune mediated disease of the skin and joints. It can have a significant negative impact on the physical, emotional, and, psychosocial wellbeing of affected ...
BMJ11d
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA Correspondence to Dr Sherine E Gabriel, Department of Health Sciences Research, Mayo Foundation, 200 First Street SW, ...
BMJ12d
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Correspondence to Martin Aringer, Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden D-01307, Germany; martin.aringer{at}uniklinikum-dresden.de; Dr ...
BMJ14d
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
12 Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece 13 Department of Medicine, Tufts University School of Medicine, Boston, USA 14 Harvard School of ...